In an interview during the 2016 American Society of Hematology Annual Meeting, Dr. John Leonard discusses results from a phase III trial where researchers compared the treatments R-CHOP to DA-EPOCH-R in DLBCL patients specifically from either the GCB or ABC subtypes.
A full link to the video of Dr. Leonard discussing the trial can be found by clicking above or be seen on Healio.com.
New Developments in Lymphoma 